Funds News
January 22, 2018 / 1:20 PM / a year ago

BRIEF-Eureka Therapeutics Closes $60 Mln In Series D Financing

1 Min Read

Jan 22 (Reuters) - EUREKA THERAPEUTICS:

* EUREKA THERAPEUTICS CLOSES $60 MILLION IN SERIES D FINANCING TO ADVANCE PROPRIETARY ARTEMIS™ T CELL RECEPTOR PLATFORM FOR SAFER T CELL THERAPIES

* EUREKA THERAPEUTICS - ACORN PACIFIC VENTURES LED ROUND, WITH PARTICIPATION FROM GP CAPITAL AND ALL EXISTING MAJOR INVESTORS Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.